生葡萄糖烯酸盐通过PI3K/AKT/HIF-1α通路抑制宫癌细胞的增殖和血管生成
Sitong Liu1,2, Zhiyi Ai1,2, Yue Hu1,2
1College of Food Science and Engineering, Jilin Agricultural University, Changchun, China.
NPJ science of food
|December 20, 2024
概括
人参葡萄糖烯酸盐 (GGO) 能够有效地抑制宫癌细胞的增殖和血管生成. 这种天然化合物在体内抑制了瘤生长,没有副作用,显示出作为抗癌功能性食物的潜力.
科学领域:
- 自然产品 化学 化学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 人参 (帕纳克斯人参C.A. 梅耶) 是一个受欢迎的功能性食品成分.
- 人参的关键化合物金色诺化物表现出已知的抗瘤活性.
- 丁香酸罗可以通过酶方式转化为丁香糖烯酸酸盐 (GGO).
研究的目的:
- 评估GGO对子宫癌的抗癌作用.
- 研究GGO的作用机制,包括增殖和血管新生抑制.
- 在临床前模型中评估GGO的疗效和安全性.
主要方法:
- 使用HeLa细胞和人类静脉内皮细胞 (HUVEC) 的体外研究.
- 在体内评估使用的胆膜 (CAM),Matrigel插头和免疫功能低下的老鼠异种移植模型.
- 细胞循环,血管生成和关键信号通路 (VEGF/VEGFR2,PI3K/AKT/HIF-1α) 的分析.
主要成果:
- GGO显著抑制了HeLa细胞活力,殖民地形成,并诱导了G0/G1细胞周期停止.
- 在多个模型中,GGO显示出抗血管性质.
- 在体内,GGO抑制了瘤生长,没有观察到副作用,与VEGF/VEGFR2和PI3K/AKT/HIF-1α通路的干扰有关.
结论:
- 人参葡萄糖烯酸盐 (GGO) 具有显著的抗宫癌特性.
- GGO通过特定的分子通路抑制癌细胞的增殖和血管生成.
- 作为一种功能性食品成分,GGO显示出用于癌症预防和治疗的前景.
相关概念视频
02:34Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
01:24Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
01:22PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
01:19Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K